Previous 10 | Next 10 |
InMode (NASDAQ:INMD) is scheduled to announce Q3 earnings results on Thursday, November 12th, before market open.The consensus EPS Estimate is $0.48 (+14.3% Y/Y) and the consensus Revenue Estimate is $52.62M (+31.5% Y/Y).Over the last 1 year, INMD has beaten EPS estimates 75% of the time and ...
Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform SimpleSENSE provides a continuous, simultaneous, and synchronous assessment of the heart, lungs, and upper vascular system without the need for an in-person docto...
InMode Announces US Patent for Fractional RF (Morpheus8) InMode Protects Intellectual Property for Its Fractionated Radiofrequency Morpheus8 Technology PR Newswire LAKE FOREST, Calif., Nov. 11, 2020 LAKE FOREST, Calif. , Nov. 11, 2020 /PRNewswire/ -- ...
Plume Effect of Fractional Radiofrequency Versus Laser Resurfacing: Considerations in the COVID Pandemic PR Newswire LAKE FOREST, Calif., Nov. 10, 2020 LAKE FOREST, Calif. , Nov. 10, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD ), a leading glo...
InMode to Present at Upcoming Virtual Investor Conferences in November PR Newswire YOKNEAM, Israel, Nov. 2, 2020 YOKNEAM, Israel , Nov. 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD ), a leading global provider of innovative ...
InMode Introduces Morpheus8 Body Multi-pulse Burst Technology PR Newswire LAKE FOREST, Calif., Oct. 20, 2020 LAKE FOREST, Calif. , Oct. 20, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD ) ("InMode"), a leading global provider of innovative medic...
Shares of InMode (NASDAQ: INMD) jumped on Tuesday after the medical technology specialist released preliminary third-quarter results. As of 2:50 p.m. EDT, InMode's stock was up more than 8% after rising as much as 14.5% earlier in the day. InMode expects to deliver record revenu...
For Q3, InMode (INMD) +22.1% PM, expects revenues in the range of $59.2 to $59.5M.Non-GAAP EPS seen ranging between $0.60 to $0.62.Non-GAAP gross margin for FY20 in the range of 84 to 86%."We expect the underlying interest in our differentiated product suite will continue to drive sales ...
InMode Expects Record Third Quarter Results, Revenues Between $59.2-$59.5M, Non-GAAP Earnings per Diluted Share Between $0.60-$0.62; Increasing Full Year 2020 Revenue Guidance to $192-$195M - Conference call to be held on November 12 at 8:30 a.m. Eastern Time PR Newswire ...
Gainers: [[JAX]] +4.5%. [[AXGT]] +4.4%. [[HRI]] +3.1%. [[AVDL]] +2.3%. [[AAL]] +1.7%.Losers: [[TATT]] -6.2%. [[FNKO]] -3.5%. [[IMGN]] -3.0%. [[VIVO]] -2.6%. [[INMD]] -1.6%. For further details see: AXGT, AVDL, INMD and IMGN among after-hours movers
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...